HEADER LIGASE 22-FEB-20 6Y4Q TITLE STRUCTURE OF A STAPLED PEPTIDE BOUND TO MDM2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE MDM2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DOUBLE MINUTE 2 PROTEIN,HDM2,ONCOPROTEIN MDM2,RING-TYPE E3 COMPND 5 UBIQUITIN TRANSFERASE MDM2,P53-BINDING PROTEIN MDM2; COMPND 6 EC: 2.3.2.27; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ACE-LEU-THR-PHE-GLY-GLU-TYR-TRP-ALA-GLN-LEU-ALA-SER; COMPND 11 CHAIN: C, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS MDM2, P53, STAPLED, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR T.PANTELEJEVS,I.BAKANOVYCH REVDAT 3 24-JAN-24 6Y4Q 1 REMARK REVDAT 2 29-JUL-20 6Y4Q 1 JRNL REVDAT 1 20-MAY-20 6Y4Q 0 JRNL AUTH A.V.STRIZHAK,O.BABII,S.AFONIN,I.BAKANOVICH,T.PANTELEJEVS, JRNL AUTH 2 W.XU,E.FOWLER,R.EAPEN,K.SHARMA,M.O.PLATONOV,V.V.HURMACH, JRNL AUTH 3 L.ITZHAKI,M.HYVONEN,A.S.ULRICH,D.R.SPRING,I.V.KOMAROV JRNL TITL DIARYLETHENE MOIETY AS AN ENTHALPY-ENTROPY SWITCH: JRNL TITL 2 PHOTOISOMERIZABLE STAPLED PEPTIDES FOR MODULATING P53/MDM2 JRNL TITL 3 INTERACTION. JRNL REF ORG.BIOMOL.CHEM. V. 18 5359 2020 JRNL REFN ESSN 1477-0539 JRNL PMID 32390036 JRNL DOI 10.1039/D0OB00831A REMARK 2 REMARK 2 RESOLUTION. 1.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 21751 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1086 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.63 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.80 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 436 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2852 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 419 REMARK 3 BIN R VALUE (WORKING SET) : 0.2815 REMARK 3 BIN FREE R VALUE : 0.3857 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 17 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1704 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 126 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.98 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.96990 REMARK 3 B22 (A**2) : -3.83320 REMARK 3 B33 (A**2) : 4.80310 REMARK 3 B12 (A**2) : -4.63900 REMARK 3 B13 (A**2) : 0.53380 REMARK 3 B23 (A**2) : 3.37690 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.240 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.121 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.113 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.123 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.115 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1938 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2640 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 691 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 384 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1938 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 233 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2541 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.38 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6Y4Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1292106756. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 63 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.31 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21777 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.630 REMARK 200 RESOLUTION RANGE LOW (A) : 44.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.16200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.46200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5AFG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% W/V PEG 8000 (PRECIPITANT), 0.1 M REMARK 280 TRIS-HCL PH 7.0 (BUFFER), 0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE REMARK 280 (SALT), VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU A 37 N CA C O CB CG CD1 REMARK 480 LEU A 37 CD2 REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 248 DISTANCE = 5.97 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 0 and LEU C 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide O9E C 1001 and GLY C REMARK 800 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide O9E C 1001 and ALA C REMARK 800 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE D 0 and LEU D 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide O9E D 101 and ALA D REMARK 800 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide O9E D 101 and GLY D REMARK 800 4 DBREF 6Y4Q A 17 108 UNP Q00987 MDM2_HUMAN 17 108 DBREF 6Y4Q B 17 108 UNP Q00987 MDM2_HUMAN 17 108 DBREF 6Y4Q C 0 12 PDB 6Y4Q 6Y4Q 0 12 DBREF 6Y4Q D 0 12 PDB 6Y4Q 6Y4Q 0 12 SEQADV 6Y4Q ALA A 69 UNP Q00987 GLU 69 ENGINEERED MUTATION SEQADV 6Y4Q ALA A 70 UNP Q00987 LYS 70 ENGINEERED MUTATION SEQADV 6Y4Q ALA B 69 UNP Q00987 GLU 69 ENGINEERED MUTATION SEQADV 6Y4Q ALA B 70 UNP Q00987 LYS 70 ENGINEERED MUTATION SEQRES 1 A 92 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 A 92 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 A 92 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 A 92 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 A 92 ALA ALA GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 A 92 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 A 92 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 A 92 VAL SEQRES 1 B 92 SER GLN ILE PRO ALA SER GLU GLN GLU THR LEU VAL ARG SEQRES 2 B 92 PRO LYS PRO LEU LEU LEU LYS LEU LEU LYS SER VAL GLY SEQRES 3 B 92 ALA GLN LYS ASP THR TYR THR MET LYS GLU VAL LEU PHE SEQRES 4 B 92 TYR LEU GLY GLN TYR ILE MET THR LYS ARG LEU TYR ASP SEQRES 5 B 92 ALA ALA GLN GLN HIS ILE VAL TYR CYS SER ASN ASP LEU SEQRES 6 B 92 LEU GLY ASP LEU PHE GLY VAL PRO SER PHE SER VAL LYS SEQRES 7 B 92 GLU HIS ARG LYS ILE TYR THR MET ILE TYR ARG ASN LEU SEQRES 8 B 92 VAL SEQRES 1 C 13 ACE LEU THR PHE GLY GLU TYR TRP ALA GLN LEU ALA SER SEQRES 1 D 13 ACE LEU THR PHE GLY GLU TYR TRP ALA GLN LEU ALA SER HET ACE C 0 3 HET ACE D 0 3 HET O9E C1001 42 HET O9E D 101 42 HETNAM ACE ACETYL GROUP HETNAM O9E ~{N}-[(1-ETHYL-1,2,3-TRIAZOL-4-YL)METHYL]-~{N},5- HETNAM 2 O9E DIMETHYL-4-[2-[2-METHYL-5-[METHYL-[(1-PROPYL-1,2,3- HETNAM 3 O9E TRIAZOL-4-YL)METHYL]CARBAMOYL]THIOPHEN-3- HETNAM 4 O9E YL]CYCLOPENTEN-1-YL]THIOPHENE-2-CARBOXAMIDE FORMUL 3 ACE 2(C2 H4 O) FORMUL 5 O9E 2(C30 H38 N8 O2 S2) FORMUL 7 HOH *126(H2 O) HELIX 1 AA1 PRO A 20 GLU A 25 1 6 HELIX 2 AA2 LYS A 31 SER A 40 1 10 HELIX 3 AA3 MET A 50 LYS A 64 1 15 HELIX 4 AA4 ASP A 80 GLY A 87 1 8 HELIX 5 AA5 GLU A 95 ARG A 105 1 11 HELIX 6 AA6 PRO B 20 THR B 26 1 7 HELIX 7 AA7 LYS B 31 VAL B 41 1 11 HELIX 8 AA8 MET B 50 ARG B 65 1 16 HELIX 9 AA9 ASP B 80 GLY B 87 1 8 HELIX 10 AB1 GLU B 95 ARG B 105 1 11 HELIX 11 AB2 THR C 2 SER C 12 1 11 HELIX 12 AB3 THR D 2 SER D 12 1 11 SHEET 1 AA1 2 LEU A 27 VAL A 28 0 SHEET 2 AA1 2 TYR A 48 THR A 49 -1 O TYR A 48 N VAL A 28 SHEET 1 AA2 2 ILE A 74 TYR A 76 0 SHEET 2 AA2 2 SER A 90 SER A 92 -1 O PHE A 91 N VAL A 75 SHEET 1 AA3 2 LEU B 27 VAL B 28 0 SHEET 2 AA3 2 TYR B 48 THR B 49 -1 O TYR B 48 N VAL B 28 SHEET 1 AA4 2 ILE B 74 TYR B 76 0 SHEET 2 AA4 2 SER B 90 SER B 92 -1 O PHE B 91 N VAL B 75 LINK C ACE C 0 N LEU C 1 1555 1555 1.33 LINK CA GLY C 4 C6 O9E C1001 1555 1555 1.51 LINK CB ALA C 11 C22 O9E C1001 1555 1555 1.48 LINK C ACE D 0 N LEU D 1 1555 1555 1.33 LINK CA GLY D 4 C6 O9E D 101 1555 1555 1.49 LINK CB ALA D 11 C22 O9E D 101 1555 1555 1.50 SITE 1 AC1 7 PRO A 32 LYS A 36 GLN A 72 HOH A 222 SITE 2 AC1 7 THR C 2 GLU C 5 TYR C 6 SITE 1 AC2 16 LYS A 51 PHE A 55 GLN A 59 HOH A 209 SITE 2 AC2 16 LYS B 51 PHE B 55 ALA B 70 HOH B 220 SITE 3 AC2 16 THR C 2 PHE C 3 GLU C 5 TYR C 6 SITE 4 AC2 16 TRP C 7 ALA C 8 ALA C 11 O9E D 101 SITE 1 AC3 16 GLN A 24 LYS A 51 PHE A 55 GLN A 59 SITE 2 AC3 16 HOH A 209 LYS B 51 PHE B 55 ALA B 70 SITE 3 AC3 16 GLY C 4 GLU C 5 TRP C 7 ALA C 8 SITE 4 AC3 16 GLN C 9 LEU C 10 SER C 12 O9E D 101 SITE 1 AC4 7 GLN B 72 THR D 2 GLU D 5 TYR D 6 SITE 2 AC4 7 GLN D 9 HOH D 201 HOH D 208 SITE 1 AC5 15 LYS A 51 PHE A 55 GLN B 24 LYS B 51 SITE 2 AC5 15 PHE B 55 HOH B 232 O9E C1001 PHE D 3 SITE 3 AC5 15 GLY D 4 GLU D 5 TRP D 7 ALA D 8 SITE 4 AC5 15 GLN D 9 LEU D 10 SER D 12 SITE 1 AC6 14 LYS A 51 PHE A 55 LYS B 51 PHE B 55 SITE 2 AC6 14 HOH B 232 O9E C1001 THR D 2 PHE D 3 SITE 3 AC6 14 GLU D 5 TYR D 6 TRP D 7 ALA D 8 SITE 4 AC6 14 ALA D 11 HOH D 211 CRYST1 34.240 34.840 48.410 93.38 107.38 117.45 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029206 0.015171 0.013020 0.00000 SCALE2 0.000000 0.032344 0.007722 0.00000 SCALE3 0.000000 0.000000 0.022253 0.00000